These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 20864679)

  • 1. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
    Puntambekar SS; Moutinho M; Lin PB; Jadhav V; Tumbleson-Brink D; Balaji A; Benito MA; Xu G; Oblak A; Lasagna-Reeves CA; Landreth GE; Lamb BT
    Mol Neurodegener; 2022 Jun; 17(1):47. PubMed ID: 35764973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
    Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
    Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.
    Mecca C; Giambanco I; Donato R; Arcuri C
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling.
    Mao M; Xu Y; Zhang XY; Yang L; An XB; Qu Y; Chai YN; Wang YR; Li TT; Ai J
    J Neuroinflammation; 2020 Aug; 17(1):244. PubMed ID: 32819407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced fear and altered neuronal activation in forebrain limbic regions of CX3CR1-deficient mice.
    Schubert I; Ahlbrand R; Winter A; Vollmer L; Lewkowich I; Sah R
    Brain Behav Immun; 2018 Feb; 68():34-43. PubMed ID: 28943292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer's disease mouse models.
    Wasén C; Beauchamp LC; Vincentini J; Li S; LeServe DS; Gauthier C; Lopes JR; Moreira TG; Ekwudo MN; Yin Z; da Silva P; Krishnan RK; Butovsky O; Cox LM; Weiner HL
    Nat Commun; 2024 May; 15(1):3872. PubMed ID: 38719797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin F (
    Daniels MJD; Lefevre L; Szymkowiak S; Drake A; McCulloch L; Tzioras M; Barrington J; Dando OR; He X; Mohammad M; Sasaguri H; Saito T; Saido TC; Spires-Jones TL; McColl BW
    Elife; 2023 Dec; 12():. PubMed ID: 38085657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute β-amyloid infusion model.
    Lee JW; Mizuno K; Watanabe H; Lee IH; Tsumita T; Hida K; Yawaka Y; Kitagawa Y; Hasebe A; Iimura T; Kong SW
    J Neuroinflammation; 2024 Aug; 21(1):196. PubMed ID: 39107821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer's disease model.
    Zhao Q; Maci M; Miller MR; Zhou H; Zhang F; Algamal M; Lee YF; Hou SS; Perle SJ; Le H; Russ AN; Lo EH; Gerashchenko D; Gomperts SN; Bacskai BJ; Kastanenka KV
    Mol Neurodegener; 2023 Dec; 18(1):93. PubMed ID: 38041158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents.
    Cipriani R; Villa P; Chece G; Lauro C; Paladini A; Micotti E; Perego C; De Simoni MG; Fredholm BB; Eusebi F; Limatola C
    J Neurosci; 2011 Nov; 31(45):16327-35. PubMed ID: 22072684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early chronic suppression of microglial p38α in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    Braun DJ; Frazier HN; Davis VA; Coleman MJ; Rogers CB; Van Eldik LJ
    PLoS One; 2023; 18(5):e0286495. PubMed ID: 37256881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model.
    Huang Y; Rafael Guimarães T; Todd N; Ferguson C; Weiss KM; Stauffer FR; McDermott B; Hurtle BT; Saito T; Saido TC; MacDonald ML; Homanics GE; Thathiah A
    Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2204828119. PubMed ID: 36161942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling.
    Frias-Anaya E; Gallego-Gutierrez H; Gongol B; Weinsheimer S; Lai CC; Orecchioni M; Sriram A; Bui CM; Nelsen B; Hale P; Pham A; Shenkar R; DeBiasse D; Lightle R; Girard R; Li Y; Srinath A; Daneman R; Nudleman E; Sun H; Guma M; Dubrac A; Mesarwi OA; Ley K; Kim H; Awad IA; Ginsberg MH; Lopez-Ramirez MA
    Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1246-1264. PubMed ID: 38660801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer's amyloid pathology.
    Fan Q; Gayen M; Singh N; Gao F; He W; Hu X; Tsai LH; Yan R
    J Exp Med; 2019 Aug; 216(8):1891-1903. PubMed ID: 31209068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation.
    Chidambaram H; Das R; Chinnathambi S
    Cell Biosci; 2020; 10():109. PubMed ID: 32944223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease.
    Daily KP; Badr A; Eltobgy M; Estfanous S; Whitham O; Tan MH; Carafice C; Krause K; McNamara A; Hamilton K; Houle S; Gupta S; Gupta GA; Madhu S; Fitzgerald J; Saadey AA; Laster B; Yan P; Webb A; Zhang X; Pietrzak M; Kokiko-Cochran ON; Ghoneim HE; Amer AO
    Alzheimers Res Ther; 2024 Feb; 16(1):29. PubMed ID: 38326859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Socs3 in LysM
    Du X; Penalva R; Little K; Kissenpfennig A; Chen M; Xu H
    Mol Neurodegener; 2021 Feb; 16(1):9. PubMed ID: 33602265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer's Disease.
    Romero-Molina C; Navarro V; Jimenez S; Muñoz-Castro C; Sanchez-Mico MV; Gutierrez A; Vitorica J; Vizuete M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus 1 accelerates the progression of Alzheimer's disease by modulating microglial phagocytosis and activating NLRP3 pathway.
    Wang Z; Liu J; Han J; Zhang T; Li S; Hou Y; Su H; Han F; Zhang C
    J Neuroinflammation; 2024 Jul; 21(1):176. PubMed ID: 39026249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.